BON Announces Advancement in Sulforaphane, Paving the Way for Rapid Development of Broccoli Extract Products
BON Announces Advancement in Sulforaphane, Paving the Way for Rapid Development of Broccoli Extract Products
Bon Natural Life Limited (NASDAQ:BON) ("BON" or the "Company"), a leading bio-ingredient solution provider in the natural, health and personal care industry, announced an achievement in converting glucoraphanin into sulforaphane, an active ingredient in broccoli extract.
天然、健康和個人護理行業領先的生物原料解決方案提供商Bon Natural Life Limited（納斯達克股票代碼：BON）（“BON” 或 “公司”）宣佈在將葡萄球菌素轉化爲蘿蔔硫素（西蘭花提取物中的活性成分）方面取得的成就。
BON's dedicated R&D team has conducted extensive research, and completed the design of a new compound system, that, when introduced into the human body, integrates enzymes with broccoli extract, efficiently catalyzing glucoraphanin, a precursor, into sulforaphane. This technological advancement not only boosts the transformation rate and bioavailability of broccoli extract, but also reduces costs significantly, allowing for rapid market expansion. Additionally, it extends the shelf life of extract products, providing convenience to customers.
BON的專業研發團隊進行了廣泛的研究，並完成了新的化合物系統的設計，該系統在引入人體後，會將酶與西蘭花提取物結合在一起，有效地催化前體葡萄球菌素進入蘿蔔硫素。這項技術進步不僅提高了西蘭花提取物的轉化率和生物利用度，而且還顯著降低了成本，從而實現了快速的市場擴張。此外，它還延長了提取物的保質期，爲客戶提供了便利。
Based on this new design, BON plans to launch a series of new health supplement products under the registered trademark: Broclife in areas of sleep improvement, digestive health, and immune health, seeking to meet the market demand for natural health products.
基於這種新設計，BON計劃在睡眠改善、消化健康和免疫健康領域推出一系列註冊商標爲Broclife的新型保健品產品，以滿足市場對天然健康產品的需求。
Recognized for its numerous health benefits such as antioxidant, anti-aging, anti-inflammatory effects, immune enhancement, inhibition of cancer cell replication, support for digestive health, and promotion of the central nervous system, broccoli extract is a highly valuable ingredient. However, its application has been limited due to challenges related to formulation effectiveness and the high costs involved in production.
西蘭花提取物因其諸多健康益處而聞名，例如抗氧化、抗衰老、抗炎作用、增強免疫力、抑制癌細胞複製、支持消化系統健康和促進中樞神經系統，是一種非常有價值的成分。但是，由於與配方有效性相關的挑戰和生產所涉及的高成本，其應用受到限制。
Yongwei Hu, CEO & Chairman of BON, stated, "We believe that our new Broclife products will address the challenges related to both effectiveness and costs in broccoli extract products, and play a crucial role in the global health market. With this innovation, BON hopes to unleash substantial growth with the hope to reach a projected of market of tens of millions of dollars over the next three years. This achievement will not only drive the Company's expansion but also deliver exceptional performance and value to our shareholders."
BON首席執行官兼董事長鬍永偉表示：“我們相信，我們的新Broclife產品將解決與西蘭花提取物產品的有效性和成本相關的挑戰，並在全球健康市場中發揮至關重要的作用。通過這項創新，BON希望實現可觀的增長，並希望在未來三年內達到數千萬美元的市場規模。這一成就不僅將推動公司的擴張，還將爲我們的股東帶來卓越的業績和價值。”
譯文內容由第三人軟體翻譯。